Dana Farber Cancer Institute Longwood Medical Center — Boston, Massachusetts

Dana Farber Cancer Institute Longwood Medical Center is a clinical research site located in Boston, Massachusetts, United States 02215-5418.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute Longwood Medical Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Mantle Cell Lymphoma, B Cell Lymphoma.

Sponsors: BeOne Medicines.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute Longwood Medical Center?

Dana Farber Cancer Institute Longwood Medical Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute Longwood Medical Center conducted?

Dana Farber Cancer Institute Longwood Medical Center has 1 clinical trials on record, with 1 currently active. Their work covers Mantle Cell Lymphoma, B Cell Lymphoma.

Is Dana Farber Cancer Institute Longwood Medical Center accredited by Crixeo Health?

Dana Farber Cancer Institute Longwood Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute Longwood Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.